Neurexis Therapeutics Email Format
Biotechnology ResearchColorado, United States2-10 Employees
Neurexis is developing an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia.
| Neurexis Therapeutics Email Formats | Percentage |
| First.Last@neurexistherapeutics.com | 50% |
| First.Last@neurexistherapeutics.com | 50% |
Biotechnology ResearchColorado, United States2-10 Employees
Neurexis is developing an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.